So Phase 3 is going to be similar to phase 2 that the primary endpoints need to be successful ?
1. Absolute change from baseline in inflammatory and absolute change from baseline in noninflammatory lesion at Week 12; and
2. Proportion of patients with an Investigators Global Assessment (IGA) of “clear” or “almost clear” and at least a 2-grade improvement in IGA from baseline at Week 12.
So Phase 3 is going to be similar to phase 2 that the primary...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.020(5.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $2.264M | 5.785M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 790722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 231350 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |